Manufacturing

Articles

The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.

WuXi and Pall Establish Continuous MAb Manufacture

CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.

Celonic Acquires Glycotope’s Biomanufacturing Facility

The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.

Catalent and Grid Therapeutics Form Immuno-Oncology Pact

As part of the $900-million deal, Incyte will pay $150 million upfront to develop and commercialize an anti-PD-1 drug candidate from biopharmaceutical company, MacroGenics.

Incyte and MacroGenics in mAb Deal Worth Up to $900 Million

AbbVie will pay a $205-million upfront payment and have the option to develop and commercialize two antibody targets globally.

AbbVie and Alector Partner on Alzheimer’s Disease Immunotherapies

ABEC, an equipment and engineering company, will provide a custom-made, single-use bioreactor to custom manufacturing firm, Emergent, for its Maryland manufacturing facility. 

ABEC Develops Single-Use Bioreactor for Emergent Manufacturing Facility

The biopharmaceutical company has received a $4.2-million grant from the Bill & Melinda Gates Foundation to invest in the development of new treatments for Enterotoxigenic Escherichia coli infections, a bacterial cause of diarrhea in the developing world.

Ventria Bioscience Receives $4.2-Million Grant for Intestinal Infection Treatments

The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.

Lilly to Invest $72 Million for Insulin Manufacturing Upgrade

The clinical-stage biopharmaceutical company has announced the opening of a new gene therapy manufacturing facility in Modiin, Israel, which is anticipated to be the production site of the company’s lead cancer drug candidate.

VBL Therapeutics Opens New Gene Therapy Manufacturing Facility

This approval marks the second gene therapy to be approved by FDA and the first to be approved for certain types of non-Hodgkin lymphoma.

Manufacturing, Biologic Drugs